Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Sukhatme Mayukh
Over the trailing 90 days, Sukhatme Mayukh (Director at Roivant Sciences Ltd.) traded $39.6M of stock (net selling $31.9M) in ROIV, per 7 SEC Form 4 transactions.
- Role
- Director
- Companies
- ROIV
- Window
- Trailing 90 days · 7 transactions · CIK 1750050
- Net activity
- −$31.9M ($3.9M bought · $35.8M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 7 | $3.9M | $35.8M | −$31.9M |
Transactions (7)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-30 | ROIV | Sell | 46.9K | $1.7M | Payment of exercise price or tax liability by delivering securities |
| 2026-06-26 | ROIV | Sell | 500.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-26 | ROIV | Buy | 500.0K | $1.9M | Exercise or conversion of derivative security |
| 2026-06-26 | ROIV | Sell | 500.0K | $17.0M | Open market or private sale |
| 2026-06-25 | ROIV | Sell | 500.0K | $17.1M | Open market or private sale |
| 2026-06-25 | ROIV | Sell | 500.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-25 | ROIV | Buy | 500.0K | $1.9M | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Sukhatme's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.